LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 26,101 Value ($000) $51 Avg Close — Range —